NasdaqGS - Delayed Quote USD
Spyre Therapeutics, Inc. (SYRE)
At close: October 21 at 4:00 PM EDT
After hours: October 21 at 4:01 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 3,639,680 | 1 |
| Sales | 18,531 | 1 |
| Net Shares Purchased (Sold) | 3,621,149 | 2 |
| Total Insider Shares Held | 2M | -- |
| % Net Shares Purchased (Sold) | -223.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BURROWS SCOTT L. Chief Financial Officer | Sale at price 28.17 per share. | Direct | 522,074 | Sep 3, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Apr 25, 2024 |
| TURTLE CAMERON Chief Executive Officer | Stock Award(Grant) at price 22.56 per share. | Direct | 9,024 | Feb 15, 2024 |
| BURROWS SCOTT L. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 22, 2023 |
| ALBERS JEFFREY W Director | -- | Indirect | -- | Nov 24, 2023 |
| TURTLE CAMERON Chief Executive Officer | -- | Direct | -- | Nov 24, 2023 |
| FAIRMOUNT FUNDS MANAGEMENT LLC Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Nov 24, 2023 |
Related Tickers
ORKA Oruka Therapeutics, Inc.
30.49
+2.45%
APGE Apogee Therapeutics, Inc.
52.97
-1.05%
DNTH Dianthus Therapeutics, Inc.
28.38
-2.31%
CGEM Cullinan Therapeutics, Inc.
16.20
-3.40%
TRML Tourmaline Bio, Inc.
28.31
+0.16%
LXEO Lexeo Therapeutics, Inc.
10.52
-5.40%
ANAB AnaptysBio, Inc.
35.37
+1.11%
IRON Disc Medicine, Inc.
50.77
+0.42%
NGNE Neurogene Inc.
52.66
-3.20%
KROS Keros Therapeutics, Inc.
60.30
-1.55%